Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing
Reexamination Certificate
2005-12-20
2005-12-20
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
C424S093700, C424S577000, C435S325000, C435S326000, C435S372300, C435S377000, C530S351000
Reexamination Certificate
active
06977073
ABSTRACT:
A method is described whereby dendritic cells derived from the CD34+ and CD 34−hematopoietic cell lineages are directed to become programmable antigen presenting cells. The programmed cells may be pulsed with tumor cell RNA or tumor cell RNA expression products. The protocol provides for directing the maturation of dendritic cells to become antigen presenting cells. The protocol further provides for isolating tumor cell RNA from biopsy material that has been prepared in paraffin block storage. The directed dendritic cell is provided with a plurality of tumor markers by using tumor RNA in toto, the poly A+RNA fraction or the expression product of such RNA. Once activated the dendritic cells are incubated with T4 and T8 lymphocytes to stimulate and sensitize the T lymphocytes which upon introduction either into a donor host or a nondonor recipient will provide immune response protection.
REFERENCES:
patent: 5316920 (1994-05-01), Tedder et al.
patent: 5648219 (1997-07-01), MacKay et al.
patent: 5831068 (1998-11-01), Nair et al.
patent: 5843648 (1998-12-01), Robbins et al.
patent: 5853719 (1998-12-01), Nair et al.
patent: 5994126 (1999-11-01), Steinman et al.
patent: 6586243 (2003-07-01), Cezayirli et al.
*Markowicz, J. Clinical Inv., vol. 85, Mar. 1990, p. 991-61 Caux, Blood, vol. 75 (12), Jun. 1990, p. 2292-98.
*Peters, Adv. Exp. Med. Biol., vol. 329, 1993, p. 275-80.
Cohen, Cancer Res., vol. 54(4), Feb. 1993, p. 1055-58.
*Jaffe, Ped.Path., vol 13, Nov.-Dec. 1993, p. 821-35.
*Cohen, Eur. J. Immunol., vol. 24(2), Feb. 1994, p. 315-19.
*Romani, J. Exp.Med., vol. 180, Jul. 1994, p. 83-93.
*Santiago-Schwarz Stem Cells, vol. 13, Mar. 1995, p. 186-97.
Galy, Immunity, vol. 3, Oct. 1995, p. 459-73.
*Alijagic, Eur. J. Immunol., vol. 25(11), Nov. 1995, p. 3100-07.
*van Lochen, Hum. Immunol., vol. 44(3), Nov. 1995, p. 181-88.
*Sienna, Exp. Hematol., vol. 23(14), Dec. 1995, p. 1643-49.
*Garcia, Plata, Invasion & Metastisis, 15 (3-4), 1995, p. 125-34.
*Tiemessen, Adv. Exp. Med. Biol., vol. 378, 1995, p. 85-7.
*Tjoa, Prostate, vol. 28(1), Jan. 1995, p. 65-9.
*Thomas, Arth. Rheumatism, vol. 39(1), Feb. 1996, p. 183-90.
*Cameron, J. Leuk. Biol. vol. 59(2), Feb. 1996, p. 158-71.
*Zhou, Prac. Natl. Acad. Sci., vol. 93, Mar. 1996, p. 2558-92.
*Thomas, J. Immunol., vol. 156(8), Apr. 1996, p. 3074-86.
*Saraya, Br. J., Haemotol., vol. 93, May 1996, p. 258-64.
*McLellan, Eur. J. Immunol., vol. 26(6), Jun. 1996, p. 1204-10.
*Res, Blood, vol. 87(12), Jun. 1996, p. 5196-5206.
*Cella, J. Exp. Med., vol. 184(1), Aug. 1996, p. 747- 52.
*Steinman, Exp. Hematol, vol. 24, Aug. 1996, p. 859-62.
*Caux, J. Exp.Med., vol. 184, Aug. 1996, p. 695-706.
*Bender, J. Immunol. Methods, vol. 196, Sept. 1996, p. 121-35.
*Pickl, J. Immunol., vol. 157, Nov. 1996, p. 3850-3854.
*Van Elsas, Eur. J. Immunol., vol. 26, 1996, p. 1683-89.
Romani, J. Immunol. Methods, vol. 196, 1996, p. 137-51.
*Morse, Ann. Surg., vol. 226(1), Jul. 1997, p. 6-16.
Cezayirli Cem
Silvers Mel
Belyavskyi Michail
Bradley Arant Rose & White LLP
Chan Christina
LandOfFree
Method for stimulating an immune response does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for stimulating an immune response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for stimulating an immune response will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3493452